Jeffrey H Cooper Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Jeffrey H Cooper.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Jeffrey H Cooper. Jeffrey H Cooper is Chief Financial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and SVP, Chief Financial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and VP, Chief Financial Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN).
Latest Insider Trading Transactions of Jeffrey H Cooper
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 21.51 | 25,000 | 537,750 | 179,042 | |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 14.39 | 2,500 | 35,975 | 204,042 | |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 17.86 | 8,708 | 155,525 | 206,542 | |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 17.33 | 41,964 | 727,236 | 215,250 | |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 17.54 | 4,864 | 85,315 | 257,214 | |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 35.07 | 83,036 | 2,911,989 | 40,104 | 123.1 K to 40.1 K (-67.43 %) |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 21.51 | 25,000 | 537,750 | 123,140 | 98.1 K to 123.1 K (+25.47 %) |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 14.39 | 2,500 | 35,975 | 98,140 | 95.6 K to 98.1 K (+2.61 %) |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 17.86 | 8,708 | 155,525 | 95,640 | 86.9 K to 95.6 K (+10.02 %) |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 17.33 | 41,964 | 727,236 | 86,932 | 45 K to 86.9 K (+93.32 %) |
Feb 28 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 17.54 | 4,864 | 85,315 | 44,968 | 40.1 K to 45 K (+12.13 %) |
Jan 05 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 14.39 | 2,500 | 35,975 | 262,078 | |
Jan 05 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 34.75 | 2,500 | 86,880 | 40,104 | 42.6 K to 40.1 K (-5.87 %) |
Jan 05 2012 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | M | 14.39 | 2,500 | 35,975 | 42,604 | 45.1 K to 42.6 K (-5.54 %) |
Nov 03 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 14.39 | 2,500 | 35,975 | 264,578 | |
Nov 03 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 33.26 | 2,500 | 83,145 | 40,104 | 42.6 K to 40.1 K (-5.87 %) |
Nov 03 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | M | 14.39 | 2,500 | 35,975 | 42,604 | 45.1 K to 42.6 K (-5.54 %) |
Nov 03 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Grant | A | 13.23 | 228 | 3,016 | 40,104 | 39.9 K to 40.1 K (+0.57 %) |
Oct 11 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 17.54 | 18,379 | 322,368 | 267,078 | |
Oct 11 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 34.00 | 18,379 | 624,886 | 39,876 | 58.3 K to 39.9 K (-31.55 %) |
Oct 11 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 17.54 | 18,379 | 322,368 | 58,255 | 39.9 K to 58.3 K (+46.09 %) |
Sep 29 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 17.54 | 18,379 | 322,368 | 285,457 | |
Sep 29 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 32.00 | 18,379 | 588,128 | 39,876 | 58.3 K to 39.9 K (-31.55 %) |
Sep 29 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 17.54 | 18,379 | 322,368 | 58,255 | 39.9 K to 58.3 K (+46.09 %) |
Sep 06 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 14.39 | 2,500 | 35,975 | 303,836 | |
Sep 06 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 29.41 | 2,500 | 73,513 | 39,876 | 42.4 K to 39.9 K (-5.90 %) |
Sep 06 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 14.39 | 2,500 | 35,975 | 42,376 | 39.9 K to 42.4 K (+6.27 %) |
Aug 04 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 17.33 | 18,036 | 312,564 | 306,336 | |
Aug 04 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 30.47 | 18,036 | 549,557 | 39,876 | 57.9 K to 39.9 K (-31.14 %) |
Aug 04 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 17.33 | 18,036 | 312,564 | 57,912 | 39.9 K to 57.9 K (+45.23 %) |
Jul 18 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 17.54 | 18,378 | 322,350 | 324,372 | |
Jul 18 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 30.00 | 18,378 | 551,340 | 39,876 | 58.3 K to 39.9 K (-31.55 %) |
Jul 18 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 17.54 | 18,378 | 322,350 | 58,254 | 39.9 K to 58.3 K (+46.09 %) |
Jul 06 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 14.39 | 2,500 | 35,975 | 342,750 | |
Jul 06 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 27.50 | 2,500 | 68,750 | 39,876 | 42.4 K to 39.9 K (-5.90 %) |
Jul 06 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 14.39 | 2,500 | 35,975 | 42,376 | 39.9 K to 42.4 K (+6.27 %) |
May 31 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 14.39 | 17,500 | 251,825 | 345,250 | |
May 31 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 27.50 | 17,500 | 481,250 | 37,876 | 55.4 K to 37.9 K (-31.60 %) |
May 31 2011 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | M | 14.39 | 17,500 | 251,825 | 55,376 | 72.9 K to 55.4 K (-24.01 %) |
Nov 24 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 11.74 | 11,250 | 132,075 | 302,750 | |
Nov 24 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 27.50 | 11,250 | 309,375 | 26,810 | 38.1 K to 26.8 K (-29.56 %) |
Nov 24 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | M | 14.39 | 11,250 | 161,888 | 38,060 | 49.3 K to 38.1 K (-22.81 %) |
Nov 24 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Grant | A | 11.64 | 324 | 3,770 | 26,810 | 26.5 K to 26.8 K (+1.22 %) |
Nov 01 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 11.74 | 28,750 | 337,525 | 314,000 | |
Nov 01 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 26.00 | 9,115 | 236,990 | 26,486 | 35.6 K to 26.5 K (-25.60 %) |
Nov 01 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 25.00 | 19,635 | 490,875 | 35,601 | 55.2 K to 35.6 K (-35.55 %) |
Nov 01 2010 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 11.74 | 28,750 | 337,525 | 55,236 | 26.5 K to 55.2 K (+108.55 %) |
Jun 24 2009 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 0.00 | 2,000 | 0 | 10,000 | |
Jun 24 2009 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 0.00 | 2,000 | 0 | 18,502 | 16.5 K to 18.5 K (+12.12 %) |
May 14 2009 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | A | 14.39 | 60,000 | 863,400 | 294,959 | |
May 14 2009 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Grant | A | 0.00 | 8,000 | 0 | 14,502 | 6.5 K to 14.5 K (+123.04 %) |
May 14 2009 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Grant | A | 10.93 | 1,456 | 15,916 | 6,502 | 5 K to 6.5 K (+28.85 %) |
Dec 19 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | A | 17.86 | 11,000 | 196,460 | 234,959 | |
Jul 08 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | A | 0.00 | 2,000 | 0 | 14,000 | |
Jul 08 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Grant | A | 0.00 | 2,000 | 0 | 4,075 | 2.1 K to 4.1 K (+96.39 %) |
Jul 08 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | P | 13.95 | 1,070 | 14,925 | 2,075 | 1 K to 2.1 K (+106.47 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 38.01 | 100 | 3,801 | 1,005 | 1.1 K to 1 K (-9.05 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 38.00 | 405 | 15,390 | 1,105 | 1.5 K to 1.1 K (-26.82 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.99 | 600 | 22,794 | 1,510 | 2.1 K to 1.5 K (-28.44 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.98 | 300 | 11,394 | 2,110 | 2.4 K to 2.1 K (-12.45 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.97 | 800 | 30,376 | 2,410 | 3.2 K to 2.4 K (-24.92 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.96 | 1,100 | 41,756 | 3,210 | 4.3 K to 3.2 K (-25.52 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.92 | 1,800 | 68,256 | 4,310 | 6.1 K to 4.3 K (-29.46 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.89 | 500 | 18,945 | 6,110 | 6.6 K to 6.1 K (-7.56 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.82 | 300 | 11,346 | 6,610 | 6.9 K to 6.6 K (-4.34 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 11.74 | 31,250 | 366,875 | 163,959 | |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 6.13 | 19,999 | 122,594 | 195,209 | |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 5.15 | 1,250 | 6,438 | 215,208 | |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 7.76 | 1,042 | 8,086 | 216,458 | |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 8.10 | 2,084 | 16,880 | 217,500 | |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.79 | 300 | 11,337 | 6,910 | 7.2 K to 6.9 K (-4.16 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.78 | 500 | 18,890 | 7,210 | 7.7 K to 7.2 K (-6.49 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.77 | 2,300 | 86,871 | 7,710 | 10 K to 7.7 K (-22.98 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.76 | 1,100 | 41,536 | 10,010 | 11.1 K to 10 K (-9.90 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.75 | 1,400 | 52,850 | 11,110 | 12.5 K to 11.1 K (-11.19 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.74 | 100 | 3,774 | 12,510 | 12.6 K to 12.5 K (-0.79 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.73 | 100 | 3,773 | 12,610 | 12.7 K to 12.6 K (-0.79 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.72 | 557 | 21,010 | 12,710 | 13.3 K to 12.7 K (-4.20 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.70 | 883 | 33,289 | 13,267 | 14.2 K to 13.3 K (-6.24 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.69 | 1,017 | 38,331 | 14,150 | 15.2 K to 14.2 K (-6.71 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.68 | 1,900 | 71,592 | 15,167 | 17.1 K to 15.2 K (-11.13 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.67 | 900 | 33,903 | 17,067 | 18 K to 17.1 K (-5.01 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.66 | 700 | 26,362 | 17,967 | 18.7 K to 18 K (-3.75 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.65 | 2,381 | 89,645 | 18,667 | 21 K to 18.7 K (-11.31 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.64 | 33 | 1,242 | 21,048 | 21.1 K to 21 K (-0.16 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.63 | 200 | 7,526 | 21,081 | 21.3 K to 21.1 K (-0.94 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.62 | 1,208 | 45,445 | 21,281 | 22.5 K to 21.3 K (-5.37 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.61 | 1,666 | 62,658 | 22,489 | 24.2 K to 22.5 K (-6.90 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.60 | 10,800 | 406,080 | 24,155 | 35 K to 24.2 K (-30.90 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.59 | 525 | 19,735 | 34,955 | 35.5 K to 35 K (-1.48 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.58 | 3,350 | 125,893 | 35,480 | 38.8 K to 35.5 K (-8.63 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.57 | 8,900 | 334,373 | 38,830 | 47.7 K to 38.8 K (-18.65 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.56 | 7,400 | 277,944 | 47,730 | 55.1 K to 47.7 K (-13.42 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.55 | 400 | 15,020 | 55,130 | 55.5 K to 55.1 K (-0.72 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 37.53 | 1,100 | 41,283 | 55,530 | 56.6 K to 55.5 K (-1.94 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 11.74 | 31,250 | 366,875 | 56,630 | 25.4 K to 56.6 K (+123.13 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 6.13 | 19,999 | 122,594 | 25,380 | 5.4 K to 25.4 K (+371.66 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 5.15 | 1,250 | 6,438 | 5,381 | 4.1 K to 5.4 K (+30.26 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 7.76 | 1,042 | 8,086 | 4,131 | 3.1 K to 4.1 K (+33.73 %) |
Mar 04 2008 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 8.10 | 2,084 | 16,880 | 3,089 | 1 K to 3.1 K (+207.36 %) |
Oct 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 8.10 | 12,380 | 100,278 | 219,584 | |
Oct 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 26.00 | 12,380 | 321,880 | 0 | 12.4 K to 0 (-100.00 %) |
Oct 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 8.10 | 12,380 | 100,278 | 12,380 | 0 to 12.4 K |
Sep 27 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 8.10 | 12,500 | 101,250 | 231,964 | |
Sep 27 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 24.50 | 12,500 | 306,250 | 0 | 12.5 K to 0 (-100.00 %) |
Sep 27 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 8.10 | 12,500 | 101,250 | 12,500 | 0 to 12.5 K |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 6.13 | 6,751 | 41,384 | 258,000 | |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 5.15 | 4,291 | 22,099 | 264,751 | |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 7.76 | 8,958 | 69,514 | 269,043 | |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.50 | 100 | 2,050 | 0 | 100 to 0 (-100.00 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.47 | 100 | 2,047 | 100 | 200 to 100 (-50.00 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.46 | 2,000 | 40,920 | 200 | 2.2 K to 200 (-90.91 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.37 | 900 | 18,333 | 2,200 | 3.1 K to 2.2 K (-29.03 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.36 | 500 | 10,180 | 3,100 | 3.6 K to 3.1 K (-13.89 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.35 | 1,000 | 20,350 | 3,600 | 4.6 K to 3.6 K (-21.74 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.29 | 616 | 12,499 | 4,600 | 5.2 K to 4.6 K (-11.81 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.28 | 4,800 | 97,344 | 5,216 | 10 K to 5.2 K (-47.92 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.27 | 4,854 | 98,391 | 10,016 | 14.9 K to 10 K (-32.64 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.26 | 2,286 | 46,314 | 14,870 | 17.2 K to 14.9 K (-13.32 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.25 | 200 | 4,050 | 17,156 | 17.4 K to 17.2 K (-1.15 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.23 | 100 | 2,023 | 17,356 | 17.5 K to 17.4 K (-0.57 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.18 | 100 | 2,018 | 17,456 | 17.6 K to 17.5 K (-0.57 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.15 | 100 | 2,015 | 17,556 | 17.7 K to 17.6 K (-0.57 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.14 | 200 | 4,028 | 17,656 | 17.9 K to 17.7 K (-1.12 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.13 | 644 | 12,964 | 17,856 | 18.5 K to 17.9 K (-3.48 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 20.12 | 1,500 | 30,180 | 18,500 | 20 K to 18.5 K (-7.50 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 6.13 | 6,751 | 41,384 | 20,000 | 13.2 K to 20 K (+50.95 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 5.15 | 4,291 | 22,099 | 13,249 | 9 K to 13.2 K (+47.90 %) |
Aug 20 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 7.76 | 8,958 | 69,514 | 8,958 | 0 to 9 K |
Sep 07 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 8.10 | 13,536 | 109,642 | 244,464 | |
Sep 07 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 22.50 | 13,536 | 304,560 | 0 | 13.5 K to 0 (-100.00 %) |
Sep 07 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 8.10 | 13,536 | 109,642 | 13,536 | 0 to 13.5 K |
Aug 09 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Option Exercise | M | 8.10 | 12,500 | 101,250 | 278,000 | |
Aug 09 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Sell | S | 21.00 | 12,500 | 262,500 | 0 | 12.5 K to 0 (-100.00 %) |
Aug 09 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | SVP, Chief Financia ... | Buy | M | 8.10 | 12,500 | 101,250 | 12,500 | 0 to 12.5 K |
Jun 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | A | 0.00 | 8,000 | 0 | 8,000 | |
Jun 12 2007 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | A | 17.33 | 60,000 | 1,039,800 | 290,500 | |
Dec 08 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | M | 8.10 | 14,500 | 117,450 | 230,500 | |
Dec 08 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Sell | S | 18.00 | 14,500 | 261,000 | 0 | 14.5 K to 0 (-100.00 %) |
Dec 08 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Buy | M | 8.10 | 14,500 | 117,450 | 14,500 | 0 to 14.5 K |
Nov 22 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | A | 17.54 | 60,000 | 1,052,400 | 245,000 | |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Option Exercise | M | 6.13 | 6,000 | 36,780 | 185,000 | |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Option Exercise | M | 8.10 | 20,000 | 162,000 | 191,000 | |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Sell | S | 16.00 | 6,000 | 96,000 | 0 | 6 K to 0 (-100.00 %) |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Sell | S | 16.00 | 20,000 | 320,000 | 6,000 | 26 K to 6 K (-76.92 %) |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Buy | M | 6.13 | 6,000 | 36,780 | 26,000 | 20 K to 26 K (+30.00 %) |
Aug 31 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | VP, Chief Financial ... | Buy | M | 8.10 | 20,000 | 162,000 | 20,000 | 0 to 20 K |
Mar 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | M | 6.13 | 13,500 | 82,755 | 223,500 | |
Mar 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Option Exercise | M | 5.15 | 2,000 | 10,300 | 237,000 | |
Mar 02 2006 | BMRN | BIOMARIN PHARMACEU ... | Cooper Jeffrey H | Chief Financial Off ... | Sell | S | 13.25 | 13,500 | 178,875 | 0 | 13.5 K to 0 (-100.00 %) |